ARCHIVES

FDA Committee Approves NDA for Mitxantrone

This article is from The Cancer Letter archive.

Vol. 12 No. 12 | March 21, 1986

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

Funding NCI Bypass Budget The “Very Least” Congress Could Do, Congressman Durbin Says

July 13, 1990

Cancer Patient Lobby Outlines Agenda For FDA Reform, Seeks Role In Discussion

June 23, 1995

SWOG Wins Funding For H. Pylori Trial.

November 21, 2008

NCI Health Disparities Center Will Attempt To Influence Policy, Harold Freeman Says.

November 3, 2000

Coalition On Smoking Or Health to Launch Effort at $5 Tax Increase

July 3, 1992